1. Home
  2. MLYS vs CARG Comparison

MLYS vs CARG Comparison

Compare MLYS & CARG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

N/A

Current Price

$28.41

Market Cap

2.3B

Sector

Health Care

ML Signal

N/A

Logo CarGurus Inc.

CARG

CarGurus Inc.

N/A

Current Price

$32.70

Market Cap

2.6B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
MLYS
CARG
Founded
2019
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.6B
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
MLYS
CARG
Price
$28.41
$32.70
Analyst Decision
Strong Buy
Buy
Analyst Count
7
11
Target Price
$48.67
$38.32
AVG Volume (30 Days)
841.5K
724.4K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
37.43
675.00
EPS
N/A
0.87
Revenue
N/A
$316,861,000.00
Revenue This Year
N/A
$13.89
Revenue Next Year
N/A
$8.91
P/E Ratio
N/A
$38.78
Revenue Growth
N/A
59.92
52 Week Low
$22.30
$26.39
52 Week High
$47.65
$41.22

Technical Indicators

Market Signals
Indicator
MLYS
CARG
Relative Strength Index (RSI) 64.18 33.29
Support Level $25.42 $32.67
Resistance Level $31.26 $36.46
Average True Range (ATR) 1.21 1.03
MACD 0.38 -0.50
Stochastic Oscillator 95.51 1.18

Price Performance

Historical Comparison
MLYS
CARG

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

About CARG CarGurus Inc.

CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. It provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.

Share on Social Networks: